App is temporarily unavailable
骨事通
Published by:
Beijing Yimai TechnologyLtd
Description
N/A
Screenshots
Loading...
Please wait..
骨事通 FAQ
-
Is 骨事通 free?
Yes, 骨事通 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 骨事通 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 骨事通 cost?
骨事通 is free.
-
What is 骨事通 revenue?
To get estimated revenue of 骨事通 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Belgium yet.
Ratings History
骨事通 Reviews
骨事通 Installs
Last 30 days
骨事通 Revenue
Last 30 days骨事通 Revenue and Downloads
Gain valuable insights into 骨事通 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
-
Beijing Yimai TechnologyLtd
- Languages
- English
- Recent release
- 1.7.2 (4 months ago )
- Released on
- Sep 8, 2017 (7 years ago )
- Also available in
- China , Poland , Italy , Japan , South Korea , Kuwait , Kazakhstan , Lebanon , Mexico , Malaysia , Nigeria , Netherlands , Norway , New Zealand , Peru , Philippines , Pakistan , India , Portugal , Romania , Russia , Saudi Arabia , Sweden , Singapore , Thailand , Türkiye , Taiwan , Ukraine , United States , Vietnam , South Africa , Dominican Republic , Argentina , Austria , Australia , Azerbaijan , Belgium , Brazil , Belarus , Canada , Switzerland , Chile , Colombia , Czechia , Germany , Denmark , United Arab Emirates , Algeria , Ecuador , Egypt , Spain , Finland , France , United Kingdom , Greece , Hong Kong SAR China , Hungary , Indonesia , Ireland , Israel
- Last Updated
- 3 months ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.